Evaluation of carbamazepine and clofibrate antidiuretic effect by mannitol osmolar clearance.
D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D004231:Diuresis / Q000187:drug effects*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007671:Kidney Concentrating Ability; D008297:Male; D008353:Mannitol; D009994:Osmolar Concentration; D014667:Vasopressins / Q000172:deficiency
D014667:Vasopressins; D002220:Carbamazepine; D008353:Mannitol; D002994:Clofibrate